DIA Announces 2011-2012 Board of Directors at DIA 2011
Add bookmark
DIA today announced its 2011-2012 Board of Directors. The announcement came during DIA 2011 being held June 19-23 in Chicago, IL. The Board of Directors set the overall strategy for DIA activities.
Executive Committee:
- Dr. Yves Juillet, DIA President, LEEM, France
- Ling Su, DIA President-elect, Novartis Pharmaceuticals, China
- Dr. Richard Day, DIA Immediate-past President
-
Minnie Baylor-Henry, DIA Treasurer, Johnson & Johnson Medical Devices & Diagnostics, USA
Directors:
- Michele Livesey, Livesey Consulting, USA
- Dr. Sandra Milligan, Amgen, USA
- Dr. Sandra L. Kweder, FDA, USA
- Dr. Steve Caffé, Medmmune, USA
- Truus Janse-de Hoog, Medicines Evaluation Board, The Netherlands
- Dr. Thomas Kühler, GE Healthcare Bio-Sciences, Sweden
- John A. Roberts, InfoLogix, USA
- Dr. Per Spindler, University of Copenhagen, Denmark
- Dr. Jean A Yager, BioPharm People, USA
Tags:
DIA
DIA 2011
DIA 2011-2012 Board of Directors
DIA Chicago
DIA conference
DIA meeting
DIA Board of Directors
Drug Information Association
DIA election results
